Drug · DIN 02469359
BACA RESPICLICK
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since November 1, 2017.
- Drug Identification Number (DIN)
- 02469359
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Powder
- Route
- Inhalation
- Therapeutic class (ATC)
- Salbutamol R03AC02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SALBUTAMOL (SALBUTAMOL SULFATE) | 97 MCG | ACT |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 1, 2017: NOC 19988New Drug Submission (NDS)